Evidence map›Paper›PMID 18766303›Full record

ArticleClinical & experimental metastasis2008

Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma.

Shuli Man, Yanjun Zhang, Wenyuan Gao, Lulu Yan, Chaoyi Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shuli ManSchool of Pharmaceutical Science and Technology, Tianjin University, Weijin Road, Tianjin, 300072, China.
Yanjun Zhang
Wenyuan Gao
Lulu Yan
Chaoyi Ma
Tianjin University · CNTianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclophosphamide (CTX), as a common use of chemotherapeutic agent, has some side effects in clinical treatment. In our experiments, we studied CTX-treated T739 mice using histopathology, immunohistochemistry, reverse transcription polymerase chain reaction and Western blot for markers of proliferation, angiogenesis, tumor progression and distant metastasis. As a result, CTX increased the number and area of metastases and tumor embolus in lungs by effecting on the expression of matrix metalloproteinase-2, intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-2. Taken together, it indicated that CTX enhanced the process of pulmonary metastasis by the synergistic effect of matrix-degrading proteases and adhesion proteins.

Indexed as

AdenocarcinomaAnimalsAntineoplastic Agents, AlkylatingBlotting, WesternCyclophosphamideFemaleImmunoenzyme TechniquesIntercellular Adhesion Molecule-1Lung NeoplasmsMaleMatrix Metalloproteinase 2MiceNeoplasms, Second PrimaryReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSpleenAntineoplastic Agents, AlkylatingCyclophosphamideIntercellular Adhesion Molecule-1Matrix Metalloproteinase 2RNA, MessengerTissue Inhibitor of Metalloproteinase-2Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID18766303
OpenAlexW1992734238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.